ReposiTrak (NYSE:TRAK) Director Ronald Hodge Sells 18,906 Shares

ReposiTrak Inc. (NYSE:TRAK) Director Ronald Hodge sold 18,906 shares of the business’s stock in a transaction dated Tuesday, December 23rd. The shares were sold at an average price of $13.16, for a total value of $248,802.96. Following the sale, the director owned 561,869 shares of the company’s stock, valued at approximately $7,394,196.04. This represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

ReposiTrak Stock Down 1.8%

Shares of NYSE:TRAK opened at $12.88 on Tuesday. The stock has a market capitalization of $235.58 million, a PE ratio of 35.78 and a beta of 0.39. The firm’s 50 day moving average price is $14.06 and its 200-day moving average price is $16.17. ReposiTrak Inc. has a twelve month low of $12.16 and a twelve month high of $23.72.

ReposiTrak (NYSE:TRAK) last announced its earnings results on Thursday, November 13th. The company reported $0.09 EPS for the quarter. ReposiTrak had a net margin of 30.52% and a return on equity of 14.37%. The business had revenue of $5.97 million during the quarter.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of TRAK. BNP Paribas Financial Markets increased its stake in ReposiTrak by 63.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock worth $32,000 after buying an additional 634 shares in the last quarter. Ingalls & Snyder LLC grew its position in shares of ReposiTrak by 1.3% during the second quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company’s stock worth $3,905,000 after purchasing an additional 2,554 shares in the last quarter. Tower Research Capital LLC TRC grew its position in shares of ReposiTrak by 397.3% during the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock worth $71,000 after purchasing an additional 2,892 shares in the last quarter. Ellsworth Advisors LLC raised its stake in ReposiTrak by 10.6% during the 1st quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company’s stock valued at $634,000 after purchasing an additional 2,997 shares during the period. Finally, Raymond James Financial Inc. lifted its holdings in ReposiTrak by 22.5% in the 3rd quarter. Raymond James Financial Inc. now owns 17,359 shares of the company’s stock worth $257,000 after purchasing an additional 3,185 shares in the last quarter. Institutional investors own 27.35% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on TRAK shares. Wall Street Zen downgraded ReposiTrak from a “buy” rating to a “hold” rating in a research report on Sunday, December 21st. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of ReposiTrak in a research note on Monday, December 22nd. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock has an average rating of “Hold”.

About ReposiTrak

ReposiTrak, trading on the New York Stock Exchange under the symbol TRAK, is a provider of cloud-based supply chain compliance and transparency solutions. The company’s platform enables retailers, suppliers and manufacturers to manage, share and validate product data throughout the supply chain. Through its Software-as-a-Service (SaaS) offering, ReposiTrak helps organizations ensure adherence to regulatory requirements, industry standards and retailer-specific guidelines for food safety, sustainability, labeling and quality assurance.

At the core of ReposiTrak’s offerings is its DataHub, a centralized repository that captures critical information such as product specifications, certifications, catch-weight data, temperature logs and recall notifications.